A stroke refers to permanent brain damage caused by a disruption in blood supply or bleeding. There are two primary types of stroke:
1. Ischemic Stroke: Occurs when a section of the brain is completely cut off from the blood supply.
2. Hemorrhagic Stroke: Results from damage caused by internal bleeding and pressure inside the skull.
A stroke can also result from traumatic brain injury or as a severe complication of atherosclerosis and generalized inflammation.
Early signs of a stroke include:
– Sudden numbness or paralysis on one side of the face or limbs.
– Abrupt confusion or difficulty understanding speech.
– Sudden aphasia (inability to speak).
– Dizziness, lack of coordination, or trouble walking.
Immediate medical attention is crucial, as strokes often require emergency intervention. The long-term effects depend on the region of the brain affected and may include:
– Loss of movement or sensation.
– Inability to control excretion.
– Speech impairments.
– Cognitive decline or other neuropsychiatric effects.
The first stage of stroke treatment focuses on addressing the immediate cause:
– Stopping bleeding and repairing the blood supply.
– Resuming oxygen delivery to affected areas.
To prevent further damage, it is essential to control blood pressure and manage secondary inflammatory reactions associated with brain injury.
Stroke recovery is typically a long-term process that involves extensive rehabilitation. This may include physical and occupational therapy, speech therapy, and adapting to any lasting impairments.
Mesenchymal Stem Cell Treatments for Stroke
Mesenchymal stem cells (MSCs) and their secretory exosomes have demonstrated anti-inflammatory effects in the brain. Since MSCs can differentiate into neural cells, experimental therapies involving MSCs may help regenerate lost functions and prevent secondary complications such as fibrosis.
At Biotherapy International, we offer two innovative therapies:
1. In Vivo Mobilization of Multipotent Stem Cells: Using growth factors to activate the body’s own regenerative mechanisms.
2. Low-Energy Acoustic Shockwave Therapy: Enhancing the mobilization of circulating multipotent stem cells to the central nervous system.
These approaches hold potential, but further research is needed to confirm their effectiveness. Unfortunately, current regulatory restrictions limit the use of ex vivo MSCs differentiated into brain cells.
Stroke treatment and recovery remain areas of active investigation, with promising therapies on the horizon.